APOTHEEK SLABBINCK
ActiveFrom the official registers: KBO 26 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
APOTHEEK SLABBINCK has been active since 1999 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €54,478 and a net result of -€8,038. Equity has been shrinking by about 12% per year since 2018. Its solvency ranks better than 43% of 12,757 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Overview
Official details
KBO- Status
- Active since 27-12-1999 Normal situation
- Legal form
- Private limited company
- Registered office
- Weststraat 35, 8370 Blankenberge
- Activity
- Retail sale of pharmaceutical products NACE 47730
- Establishment unit
- 2.099.939.736 8370 Blankenberge, since 05-12-2000
- Financial year end
- 31 December
- Peppol
- Reachable since 27-08-2025
Board and ownership
- PANAKEIADirector · since 31-12-2024 · permanent representative FEVERY Ellen
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.4%
- Gross margin
- €51,464
- ▼ 48.5%
- Turnover
- ≈ €250,000
- estimated
- Loss
- €8,038
- Equity
- €54,478
- ▼ 12.9%
- Total assets
- €181,970
- ▲ 22.0%
- Staff
- 0.6 FTE
- =
Score breakdownraises riskLoss of €8,038 (financial year 2025)Sector: Retail trade (NACE 47)lowers riskFounded in 1999Liquidity: current ratio 1.44, cash €32,777Show the evidence
Checked score
About 4 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 46% of them on solvency, 33% on liquidity, 19% on profitability and 24% on growth.
The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
The company filed its last 7 accounts on average 9 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
Key points
- Caution: Lower net result than 81% of companies in retail tradesector median €27,641 · 12,747 companies -€8,038 View
Documents
Annual accounts at the NBB
- Annual accounts 2025filed on 14-08-2026
- Annual accounts 2024filed on 13-08-2025
- Annual accounts 2023filed on 13-07-2024
- Annual accounts 2022filed on 18-07-2023
Acts in the Belgian Official Gazette
- Resignations & appointmentsact of 05-02-2025
- Legal-form change · Resignations & appointmentsact of 21-11-2023
Articles and registers
- Coordinated articles of associationnotaries' database
- Entry in the KBO registerKBO Public Search
Key facts about APOTHEEK SLABBINCK
- What is the company number of APOTHEEK SLABBINCK?
- The company number of APOTHEEK SLABBINCK is 0468.817.430. The VAT number is the same number with BE in front: BE 0468.817.430.
- Where is APOTHEEK SLABBINCK based?
- The registered office is at Weststraat 35, 8370 Blankenberge.Company details
- What does APOTHEEK SLABBINCK do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of APOTHEEK SLABBINCK?
- The legal form of APOTHEEK SLABBINCK is Private limited company (BV).
- When was APOTHEEK SLABBINCK founded?
- APOTHEEK SLABBINCK was founded on 27-12-1999.
- Is APOTHEEK SLABBINCK still active?
- Yes, APOTHEEK SLABBINCK is an active enterprise in the KBO register.
- How many employees does APOTHEEK SLABBINCK have?
- APOTHEEK SLABBINCK had an average of 0.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of APOTHEEK SLABBINCK?
- The turnover in financial year 2025 is ≈ €250,000. This figure is estimated from the gross margin of €51,464 and 73 comparable companies (NACE 477). It probably lies between €120,000 and €360,000.
- Is APOTHEEK SLABBINCK profitable?
- In financial year 2025, APOTHEEK SLABBINCK made a loss of €8,038.
- Where can I find the annual accounts of APOTHEEK SLABBINCK?
- APOTHEEK SLABBINCK filed 26 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
- When are the next annual accounts of APOTHEEK SLABBINCK due?
- APOTHEEK SLABBINCK must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Comparable companies
These companies have the same main activity as APOTHEEK SLABBINCK: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €182,000 and €277,000, founded between 1990 and 2003.
| Company | Total assets | Gross margin |
|---|---|---|
| APOTHEEK SLABBINCK Blankenberge | €181,970 | €51,464 |
| PHARMACIE LADEUZE Lessines | €199,883 | €60,328 |
| PHARMACIE SEVERIN Sambreville | €243,411 | €37,349 |
| APOTHEEK WINTERS BEA Peer | €228,047 | €68,302 |
| Pharmacie Closson Brasseur Beauraing | €181,935 | €35,552 |
| APOTHEEK PENEL Vorst | €277,104 | €62,805 |
| Apotheek Vanderheyden Neeroeteren Maaseik | €255,129 | €35,796 |
Next steps
See how customers, suppliers and banks see your own company and what to improve first.